Reversible decompensated liver disease as a possible complication of pegylated-interferon alfa 2B and ribavirin for recurrent hepatitis C [6]

Sandeep Mukherjee

doi:10.1111/j.1440-1746.2004.03452.x

Reversible decompensated liver disease as a possible complication of pegylated-interferon alfa 2B and ribavirin for recurrent hepatitis C [6]

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	723-724
Number of pages	2
Journal	Journal of Gastroenterology and Hepatology (Australia)
Volume	19
Issue number	6
DOIs	https://doi.org/10.1111/j.1440-1746.2004.03452.x
State	Published - Jun 2004
Externally published	Yes

All Science Journal Classification (ASJC) codes

Hepatology
Gastroenterology

Access to Document

10.1111/j.1440-1746.2004.03452.x

Cite this

@article{abe4e6430b9448f1ade56aa0fa62e41d,

title = "Reversible decompensated liver disease as a possible complication of pegylated-interferon alfa 2B and ribavirin for recurrent hepatitis C [6]",

author = "Sandeep Mukherjee",

year = "2004",

month = jun,

doi = "10.1111/j.1440-1746.2004.03452.x",

language = "English (US)",

volume = "19",

pages = "723--724",

journal = "Journal of Gastroenterology and Hepatology (Australia)",

issn = "0815-9319",

publisher = "Wiley-Blackwell",

number = "6",

}

TY - JOUR

T1 - Reversible decompensated liver disease as a possible complication of pegylated-interferon alfa 2B and ribavirin for recurrent hepatitis C [6]

AU - Mukherjee, Sandeep

PY - 2004/6

Y1 - 2004/6

UR - http://www.scopus.com/inward/record.url?scp=3042742732&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042742732&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1746.2004.03452.x

DO - 10.1111/j.1440-1746.2004.03452.x

M3 - Letter

C2 - 15151639

AN - SCOPUS:3042742732

VL - 19

SP - 723

EP - 724

JO - Journal of Gastroenterology and Hepatology (Australia)

JF - Journal of Gastroenterology and Hepatology (Australia)

SN - 0815-9319

IS - 6

ER -

Reversible decompensated liver disease as a possible complication of pegylated-interferon alfa 2B and ribavirin for recurrent hepatitis C [6]

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this